We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Protein Directs Neural Stem Cell Migration

By Biotechdaily staff writers
Posted on 22 May 2002
A specific protein has been identified as being responsible for directing the migration of neural stem cells to the appropriate location in the brain as it adapts to new information. More...
This finding was published in the March 19, 2002, issue of the Proceedings of the National Academy of Sciences.

"Neural stem cells are the precursors to the variety of cell types found in the brain, said Kiminobu Sugaya, assistant professor of psychiatry at the University of Illinois at Chicago (USA) and the study's principal investigator. "Triggered by unknown environmental cues or factors, they migrate to specific areas to become a glial cell or a neuron, forming a link in the adult brain's complex neural network.”

In the study, human neural stem cells were transplanted into an empty space of the brain, called the ventricle, in normal mice and in mice incapable of producing a protein called reelin. The mice are called reeler mice because of their peculiar gait, a result of their genetic defect. "In the reeler mice, the stem cells got lost,” Prof. Sugaya said. "They failed to migrate.”

In the normal mice, however, the cells migrated into the hippocampus, the central processing unit of the brain; the olfactory lobes, controlling the sense of smell; and the cerebral cortex, responsible for higher mental activities like learning, memory, perception and problem solving. Once located in those regions, the cells turned into mature cells capable of functioning in the new environs.

"In normal mice we found a beautiful, symmetrical migration and differentiation of the stem cells,” Prof. Sugaya said.

Not only did this study clearly identify, for the first time, the role of reelin in the adult brain, but it also allowed the researchers to suggest a possible molecular mechanism for schizophrenia, a devastating psychiatric illness characterized by a distorted perception of reality, disordered thinking, and a flat affect. In an earlier postmortem study of the brains of schizophrenics, Erminio Costa, a co-author of the present study, found that the level of reelin was half that in normal human brains. Moreover, in a blind study of 60 brains taken postmortem from individuals diagnosed with severe psychiatric disorders, Dr. Costa was able to correctly identify those that came from psychotic patients by testing for levels of reelin.

"Perhaps in schizophrenics, who lack reelin, the brain's stem cells cannot find their way to make the appropriate neural connections,” said Kiminobu Sugaya, "As a result, perception and thinking may break down.”




Related Links:
University of Illinois at Chicago

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.